Market revenue in 2023 | USD 167.9 million |
Market revenue in 2030 | USD 276.3 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Detection of latent infection (skin test & igra) |
Fastest growing segment | Detection of Drug Resistance (DST) |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Nucleic Acid Testing, Detection of Latent Infection (Skin Test & IGRA), Detection of Drug Resistance (DST), Other Methods, Phage Assay, Cytokine Detection Assay, Diagnostic Laboratory Methods, Radiographic Method |
Key market players worldwide | Abbott Laboratories, Becton Dickinson & Co, Roche Holding AG ADR, Thermo Fisher Scientific Inc, BioMerieux SA, Qiagen NV, Hologic Inc, BD, Hain Lifescience, Cepheid |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tuberculosis diagnostics market will help companies and investors design strategic landscapes.
Detection of latent infection (skin test & igra) was the largest segment with a revenue share of 41.27% in 2023. Horizon Databook has segmented the Middle East & Africa tuberculosis diagnostics market based on nucleic acid testing, detection of latent infection (skin test & igra), detection of drug resistance (dst), other methods, phage assay, cytokine detection assay, diagnostic laboratory methods, radiographic method covering the revenue growth of each sub-segment from 2018 to 2030.
Middle Eastern countries including Saudi Arabia, Qatar, United Arab Emirates (UAE), Kuwait, and Oman are prospering economies. Advancements in their healthcare system are expected to increase the demand for advanced diagnosis methods in this region.
On the contrary, some countries in the African region lack in adequate healthcare infrastructure. Moreover, frequent infectious disease epidemics enforce the usage of antibiotics significantly.
However, countries are undertaking initiatives in coordination with the WHO or other independent organizations. This is expected to help develop this market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa tuberculosis diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa tuberculosis diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account